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CASE REPORT
Lipofibromatosis-like neural tumor:
Case report of a unique infantile
presentation
Diana W. Bartenstein, BA,a,b Taylor M. Coe, MD,c Samantha C. Gordon, MD,d
Alison M. Friedmann, MD,e Maryanne M. Senna, MD,b Cassandra M. Kelleher, MD,c
Cristina R. Antonescu, MD,f Rosalynn M. Nazarian, MD,g and Elena B. Hawryluk, MD, PhDb
Boston, Massachusetts, and New York, New York
A 14-month-old boy presented with a slow-growing, asymptomatic back plaque, which was biopsied and
found to have S100 positivity, sparse CD34 staining, and no significant mitotic activity, nuclear
pleomorphism, or necrosis; genetic workup found LMNA-NTRK1 gene fusion, overall consistent with
lipofibromatosis-like neural tumor (LPF-NT). LPF-NT is rare, with 14 cases previously reported, and our
patient is the first report of this diagnosis in infancy. This case report and literature review includes
comparison of similar diagnoses including lipofibromatosis, low-grade malignant peripheral nerve
sheath tumor, infantile fibrosarcoma, and dermatofibrosarcoma protuberans and serves to aid detection
of LPF-NT presenting in pediatric patients by highlighting similarities and differences that should
prompt consideration. LPF-NT shows locally aggressive behavior only and should not be confused with
conditions that have potential for distant spread. However, case reports of metastasizing LMNA-NTRK1
tumors draw into question whether growths with this gene fusion exist on a spectrum of disease severity.
Our patient was treated with wide local excision and has developed no complications or evidence of
recurrence with 6 months of follow-up time. ( J Am Acad Dermatol 2018;4:185-8.)
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INTRODUCTION
Infantile mesenchymal tumors can range from
benign to malignant, and proper diagnosis is crucial
for patient management and counseling. Clinical
appearance is not sufficient for diagnosis, and
histopathology must be performed to determine
tumor type. Lipofibromatosis-like neural tumor
(LPF-NT) is a recently defined entity that commonly
shows infiltrative growth and spindle cells arranged
in streaming fascicles, which is similar to
lipofibromatosis, but the tumor is distinguished
by S100 protein reactivity and NTRK1 gene
rearrangements. Clinically, differential diagnoses
other than lipofibromatosis include peripheral nerve
sheath tumor, dermatofibrosarcoma protuberans,
infantile fibrosarcoma, hamartoma, myofibroma,
vascular plaque such as arteriovenous malformation,
congenital nevus with proliferative nodules, and
melanoma.
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REPORT OF A CASE
An otherwise healthy 14-month-old boy
presented for evaluation of an asymptomatic truncal
‘‘birthmark’’ that slowly grew and changed color. He
was born at 40.5 weeks via cesarean section after an
uncomplicated pregnancy. Results of lower back
ultrasound scan and radiography performed on the
fifth day of life, because of to a small tuft of hair over
the lower lumbar spine, were unremarkable. His
parents reported the tumor to be present at birth, and
his pediatrician documented a quarter-sized plaque
at his 2-month visit. At age 9 months, the tumor
measured 1.5 3 2 cm with central clearing. The
plaque was not pruritic, painful, or friable.
With presentation to the dermatology department
at age 14 months, physical examination found a 3-3
3.5-cm violaceous, hyperpigmented, atrophic pla-
que on his left lower back (Fig 1). It contained 2
prominent erythematous firm nodules, the larger
nodule measuring 1.5 cm. Magnetic resonance
imaging found a well-defined 3.8- 3 3.4- 3 0.6-cm
discoid mass involving the skin and subcutaneous
tissue with predominant T2 hyperintensity,
intermediate T1 signal, and a small internal fat signal
component.
Histology found a deep dermal and subcutaneous
spindled-cell neoplasm with fascicular growth and
infiltration into the adipose tissue but no significant
mitotic activity, nuclear pleomorphism, necrosis, or
hemangiopericytoma-like vascular proliferation
(Fig 2). Tumor cells displayed focal S100 protein
reactivity and very focal to weak CD34 staining but
were negative for desmin, smooth muscle actin,
epithelial membrane antigen, and anaplastic
lymphoma kinase. Cytoplasmic NTRK1 immunohis-
tochemistry showed diffuse positive staining (Fig 3),
and fluorescence in situ hybridization (FISH) studies
with custom Bacterial Artificial Chromosomes (BAC)
probes found NTRK1 breakapart. Further fusion
FISH assays showed LMNA-NTRK1 fusion, whereas
testing for ETV6 or EWSR1 gene rearrangements was
negative. Overall findings were most consistent with
a diagnosis of LPF-NT.
The tumor was excised with 1-cm margins. The
patient had a temporary vacuum-assisted closure
to allow for confirmation of clear margins by
formalin-fixed and paraffin-embedded pathology
evaluation, and the defect was repaired with bilateral
V-Y advancement flaps. The patient has no
complications or evidence of clinical recurrence
with 8 months of follow-up. Three months after
excision, magnetic resonance imaging showed no
definitive evidence of residual or recurrent tumor;
this finding serves as a postoperative imaging
baseline.
DISCUSSION
Lipofibromatosis (LPF) tumors, first described
in 2000 by Fetsch and colleagues,1 are rare,
Fig 1. Lipofibromatosis-like neural tumor in a 14-month-
old child, presenting as a hyperpigmented left lower back
plaque.
Fig 2. Lipofibromatosis-like neural tumor. Histopatholog-
ic sections of the skin biopsy specimen of this patient
showed fascicles of spindled tumor cells infiltrating
subcutaneous adipose tissue without significant
cytomorphologic atypia or mitotic activity. (Hematoxy-
lin-eosin stain; original magnification: 320.)
Fig 3. Lipofibromatosis-like neural tumor. NTRK1
immunohistochemistry of this patient’s tumor shows
positive staining in tumor cells (immunoreactivity
indicated by brown chromogen). (Original magnification:
310.)
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slow-growing soft tissue masses composed of
adipocytic and fibroblastic elements. In reviewing
827 fibromatous tumors from more than 30 years of
pathology data, these authors identified 45 cases
that they proposed to be classified as LPF. LPF
is distinguished from infantile and juvenile
fibromatosis by its predominantly adipocytic
composition and differentiated from fibrous
hamartoma of infancy by its lack of immature
mesenchymal tissue. Although LPF tumors are likely
to present with ill-defined margins and infiltrative
growth, they are distinguished from malignant
lesions by their absent-to-rare mitotic figures and
mild atypia.1-7
In 2016, Agaram and colleagues8 identified
LPF-NT as a related tumor distinguished by S100
protein reactivity, which is indicative of neural
differentiation. FISH analysis found that 10 of
these 14 initially reported LPF-NT cases contained
NTRK1 gene rearrangements, including TPR-NTRK1,
TPM3-NTRK1, and most commonly, LMNA-NTRK1.
In contrast, 25 typical LPF tumors showed S100
protein reactivity or NTRK1 gene abnormality.
Our case represents the first infantile LPF-NT, as
previous patients presented between the ages of 4
and 38 years. This patient had tumor admixture with
adipose tissue, which is a key feature of LPF, but
relative paucity of fat compared to previously
described cases resulted in his tumor appearing
fibrous clinically. Identification and report of further
LPF-NT cases is required to determine whether this
particular presentation is associated with his young
age, as infants are known to demonstrate different fat
distributions than older patients, as opposed to
those characteristic of LPF-NT. Nevertheless, we
recommend that LPF-NT be included in the
differential diagnosis for patients presenting with
masses that are clinically concerning for fibrous as
well as fatty tumors. Table I provides an overview of
key clinical and histopathologic features that
differentiate LPF-NT from related tumors. LPF-NT is
associated with locally aggressive behavior only and
should not be confused with tumors that distantly
metastasize.8 However, 2 sarcoma cases with the
same genetic fusion raise concern for potential
disease evolution over time. Agaram and colleagues8
describe a 37-year-old patient whose tumor was
stable for more than 20 years before growing rapidly.
Histopathologic and genetic evaluation found S100
positivity, focal CD34 positivity, and LMNA-NTRK1
gene fusion, features that are characteristic for
LPF-NT but not generally found in sarcoma, but the
tumor was distinguished as malignant by high
mitotic activity and necrosis. Wong and colleagues9
report a 7-month-old patient with a ‘‘purplish lesion
on his right buttock’’ found to have LMNA-NTRK1
gene fusion and CD34 positivity, without report of
S100 protein reactivity. This tumor was diagnosed as
infantile fibrosarcoma because of its rapid growth,
friability, vimentin positivity, and mitotic figures,
Table I. Key features of LPF-NT and related tumors
Lipofibromatosis-like
neural tumor Lipofibromatosis
Low-grade malignant
peripheral nerve
sheath tumor
Infantile
fibrosarcoma
Dermatofibrosarcoma
protuberans
Atypia Low Low Nuclear atypia
present
High Variable
Mitotic rate Low Low Low High Variable
Immunohisto
chemistry
S100 Positive Negative Positive Negative Negative
CD34 Focal to
multifocal
positivity
Variable Positive Negative Strongly positive
SOX10 Negative Not reported Variable Not reported Negative
Reported
genetic
mutations
NTRK1
rearrangement
Negative for NTRK1
rearrangement*
Neurofibromin 1,
PTEN, IGF1R,
EGFR, MAPK
ETV6-NTRK3
fusiony
91% with
COL1A1-PDGFB
fusion
Natural history Local recurrence
with incomplete
excision
Local recurrence with
incomplete excision
Potential for distant
metastasis; 50%
occur in patients with
neurofibromatosis
type I
Potential for
distant
metastasis
Potential for
distant
metastasis
*One report of balanced translocation (4;9;6).4
yOne report of LMNA-NTRK1 fusion.9
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although LMNA-NTRK1 gene fusion and CD34
positivity are not typical for this diagnosis. Both
sarcoma patients went on to have pulmonary
metastases, and the younger patient also suffered
progression to his S5 vertebral body and acetabulum.
Although these tumors were histopathologically
distinct from LPF-NT, overlapping genetic features
raise concern for the possibility that over time,
LPF-NT may accumulate genetic abnormalities and
increasingly aggressive clinical characteristics.
This case is reported to increase awareness of
LPF-NT, as identification of additional cases will
improve understanding of this rare dermatologic
condition. Surgical margin guidelines are not
available for these tumors, and LPF and LPF-NT
have been found to show local recurrence when
incompletely excised,1,8 which prompted our use of
1-cm clinical margins and confirmation of histologic
clear margins by formalin-fixed tissue before repair.
In the absence of long-term follow-up data, we
suggest early diagnosis, complete excision, and close
follow-up for those affected.
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